What level of alkaline phosphatase is dangerous?

Alkaline phosphatase (ALP) levels above 147 U/L or below 44 U/L in adults can indicate serious health issues including liver disease, bone disorders, or cancer. Extremely high levels (3-10x normal) require immediate medical attention as they may signal bile duct obstruction or advanced liver disease.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Alkaline Phosphatase and Its Role in Your Body

Alkaline phosphatase (ALP) is an enzyme found throughout your body, with the highest concentrations in your liver, bones, kidneys, and digestive system. This enzyme plays a crucial role in breaking down proteins and helping your liver function properly. When ALP levels venture outside the normal range, it can signal various health conditions that require attention.

Your body naturally produces ALP, and small fluctuations in levels are normal. However, when levels become significantly elevated or decreased, it often indicates an underlying health issue affecting your liver, bones, or other organs. Understanding what constitutes dangerous ALP levels can help you recognize when to seek medical attention and take proactive steps to protect your health.

Normal vs. Dangerous ALP Levels

Normal alkaline phosphatase levels vary based on age, sex, and laboratory standards, but generally fall within these ranges:

Alkaline Phosphatase Level Categories and Clinical Significance

ALP levels should be interpreted alongside other liver function tests and clinical symptoms for accurate diagnosis.
ALP Level (U/L)CategoryClinical SignificanceAction Required
Below 44<44 U/LLowMalnutrition, zinc deficiency, hypothyroidismMedical evaluation needed
44-14744-147 U/LNormalHealthy range for adultsNo action needed
148-300148-300 U/LMildly ElevatedEarly liver/bone disease, medication effectsFurther testing recommended
301-500301-500 U/LModerately ElevatedActive liver disease, bone disordersUrgent medical evaluation
Above 500>500 U/LSeverely ElevatedBile duct obstruction, cancer, severe diseaseEmergency medical care

ALP levels should be interpreted alongside other liver function tests and clinical symptoms for accurate diagnosis.

  • Adults: 44-147 U/L (units per liter)
  • Children and adolescents: Higher levels due to bone growth (up to 500 U/L can be normal)
  • Pregnant women: Elevated levels due to placental ALP production

Dangerous ALP levels typically fall into two categories: significantly elevated or abnormally low. High ALP levels become concerning when they exceed 147 U/L in adults, with levels 2-3 times the upper normal limit requiring immediate investigation. Extremely dangerous levels often exceed 1,000 U/L and may indicate severe liver disease, bile duct obstruction, or certain cancers.

When High ALP Levels Become Critical

Moderately elevated ALP (150-300 U/L) may indicate developing liver or bone conditions that require monitoring and further testing. However, levels exceeding 500 U/L in adults often signal serious conditions requiring immediate medical intervention. Levels above 1,000 U/L are considered medical emergencies, particularly when accompanied by symptoms like severe abdominal pain, jaundice, or unexplained weight loss.

The Dangers of Low ALP Levels

While less common, abnormally low ALP levels (below 44 U/L) can also be dangerous. Low levels may indicate malnutrition, zinc deficiency, hypothyroidism, or rare genetic conditions like hypophosphatasia. Severely low levels can affect bone health and protein metabolism, leading to increased fracture risk and poor wound healing.

Health Conditions Associated with Dangerous ALP Levels

Elevated alkaline phosphatase levels can indicate various serious health conditions. Understanding these associations helps identify when ALP levels signal danger and require immediate medical attention.

The liver is a primary source of ALP, and liver diseases often cause significant elevations. Dangerous conditions include:

  • Bile duct obstruction (can cause levels >1,000 U/L)
  • Primary biliary cholangitis
  • Liver cancer or metastases
  • Cirrhosis
  • Hepatitis

Bile duct obstruction represents one of the most dangerous causes of elevated ALP, as it can lead to liver failure if left untreated. These cases often present with ALP levels 10-20 times the normal range, accompanied by jaundice and severe abdominal pain.

Bone diseases can cause dangerous ALP elevations, particularly when rapid bone turnover occurs. Critical bone-related causes include:

  • Paget's disease of bone (levels can exceed 1,000 U/L)
  • Bone cancer or metastases
  • Multiple myeloma
  • Severe osteomalacia
  • Hyperparathyroidism

Recognizing Symptoms of Dangerous ALP Levels

While ALP levels themselves don't cause symptoms, the underlying conditions driving dangerous levels often do. Recognizing these warning signs can help you seek timely medical care.

Symptoms associated with dangerously high ALP levels include:

  • Jaundice (yellowing of skin and eyes)
  • Dark urine and pale stools
  • Severe abdominal pain, especially in the upper right quadrant
  • Unexplained weight loss
  • Persistent fatigue and weakness
  • Bone pain or frequent fractures
  • Itchy skin without rash

Low ALP levels may present with symptoms including muscle weakness, chronic fatigue, poor wound healing, and in children, delayed growth and development. These symptoms often develop gradually, making regular monitoring important for early detection.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing and Monitoring Your ALP Levels

Regular monitoring of ALP levels is crucial for detecting dangerous changes early. ALP testing is typically included in comprehensive metabolic panels and liver function tests. If you're experiencing symptoms or have risk factors for liver or bone disease, getting your ALP levels checked can provide valuable insights into your health status.

When to Get Tested

You should consider ALP testing if you experience:

  • Persistent abdominal pain or discomfort
  • Unexplained jaundice or changes in urine/stool color
  • Chronic fatigue with no clear cause
  • Bone pain or frequent fractures
  • Family history of liver or bone disease
  • Taking medications known to affect liver function

Understanding Your Test Results

When reviewing your ALP results, remember that a single elevated reading doesn't always indicate danger. Your healthcare provider will consider your complete clinical picture, including other liver enzymes (ALT, AST), bilirubin levels, and symptoms. They may order additional tests like GGT (gamma-glutamyl transferase) to determine whether elevated ALP originates from liver or bone sources.

For comprehensive health monitoring that includes ALP and other crucial liver function markers, regular testing can help you track trends over time and catch concerning changes early. Understanding your baseline levels and monitoring for significant deviations provides the best opportunity for early intervention.

Treatment Approaches for Dangerous ALP Levels

Treatment for dangerous ALP levels focuses on addressing the underlying cause rather than the enzyme level itself. The urgency and type of treatment depend on how elevated your levels are and what's causing the abnormality.

Emergency Interventions

Extremely high ALP levels (>1,000 U/L) with symptoms like severe jaundice or abdominal pain require immediate medical attention. Emergency treatments may include:

  • Endoscopic procedures to remove bile duct obstructions
  • Surgical intervention for tumors or gallstones
  • Intravenous medications for acute liver inflammation
  • Hospitalization for monitoring and supportive care

Long-term Management Strategies

For moderately elevated levels, treatment typically involves:

  • Medications specific to the underlying condition (e.g., ursodeoxycholic acid for primary biliary cholangitis)
  • Dietary modifications to support liver health
  • Vitamin D and calcium supplementation for bone-related causes
  • Regular monitoring to track treatment effectiveness
  • Lifestyle changes including alcohol cessation and weight management

Prevention and Risk Reduction

While not all causes of dangerous ALP levels are preventable, you can take steps to reduce your risk and maintain healthy enzyme levels:

  • Limit alcohol consumption to protect liver health
  • Maintain a healthy weight to reduce fatty liver disease risk
  • Exercise regularly to support bone health and metabolism
  • Avoid medications and supplements that can damage the liver without medical supervision
  • Get adequate vitamin D and calcium for bone health
  • Manage chronic conditions like diabetes that can affect liver function

Regular health screenings play a crucial role in prevention. By monitoring your ALP levels along with other liver and metabolic markers, you can identify concerning trends before they become dangerous. Early detection allows for timely intervention and better outcomes.

If you have existing blood test results that include ALP levels, you can get a comprehensive analysis of your results using SiPhox Health's free upload service. This service provides personalized insights into your biomarker levels and what they mean for your health.

Taking Action on Abnormal ALP Levels

Dangerous alkaline phosphatase levels require prompt medical attention and appropriate treatment. Whether your levels are extremely high (indicating potential liver obstruction or advanced bone disease) or abnormally low (suggesting nutritional deficiencies or metabolic disorders), working with healthcare providers to identify and address the underlying cause is essential.

Remember that ALP is just one piece of your health puzzle. Comprehensive testing that includes liver function panels, metabolic markers, and other relevant biomarkers provides the most complete picture of your health status. Regular monitoring, especially if you have risk factors or concerning symptoms, enables early detection and intervention when ALP levels begin trending toward dangerous territory.

By understanding what constitutes dangerous ALP levels and taking proactive steps to monitor and maintain your health, you can reduce your risk of serious complications and ensure timely treatment when needed. Don't wait for symptoms to become severe—if you're concerned about your ALP levels or liver health, consult with a healthcare provider and consider comprehensive testing to get the full picture of your metabolic health.

References

  1. Sharma, U., Pal, D., & Prasad, R. (2014). Alkaline phosphatase: An overview. Indian Journal of Clinical Biochemistry, 29(3), 269-278.[Link][PubMed][DOI]
  2. Lowe, D., Sanvictores, T., & John, S. (2023). Alkaline Phosphatase. In StatPearls. StatPearls Publishing.[Link][PubMed]
  3. Kalas, M. A., Chavez, L., Leon, M., Taweesedt, P. T., & Surani, S. (2021). Abnormal liver enzymes: A review for clinicians. World Journal of Hepatology, 13(11), 1688-1698.[Link][PubMed][DOI]
  4. Siddique, A., & Kowdley, K. V. (2012). Approach to a patient with elevated serum alkaline phosphatase. Clinics in Liver Disease, 16(2), 199-229.[Link][PubMed][DOI]
  5. Millán, J. L., & Whyte, M. P. (2016). Alkaline phosphatase and hypophosphatasia. Calcified Tissue International, 98(4), 398-416.[Link][PubMed][DOI]
  6. Poupon, R. (2015). Primary biliary cirrhosis: A 2010 update. Journal of Hepatology, 52(5), 745-758.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my alkaline phosphatase at home?

You can test your alkaline phosphatase at home with SiPhox Health's Heart & Metabolic Program, which includes ALP testing along with other liver function markers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is considered a dangerously high ALP level?

ALP levels above 500 U/L in adults are considered dangerously high and require immediate medical evaluation. Levels exceeding 1,000 U/L are medical emergencies, especially when accompanied by symptoms like jaundice or severe abdominal pain.

Can ALP levels be too low?

Yes, ALP levels below 44 U/L are considered abnormally low and can indicate malnutrition, zinc deficiency, hypothyroidism, or genetic conditions. Low levels can affect bone health and protein metabolism.

How quickly can ALP levels change?

ALP levels can change within days to weeks depending on the underlying cause. Acute bile duct obstruction can cause rapid elevations within 24-48 hours, while chronic conditions typically show gradual changes over weeks to months.

Should I fast before an ALP test?

Fasting is not typically required for ALP testing alone, but it may be necessary if other tests are being performed simultaneously. ALP levels can be slightly elevated after eating, particularly after fatty meals.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details